V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2) Peptide
-
- Target See all AKT2 products
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- Origin
- Human, Mouse, Chicken, Dog, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-AKT2 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- Synonyms
- AKT2 Peptide, pkbb Peptide, pkbbeta Peptide, pkbss Peptide, prkbb Peptide, rac-beta Peptide, v-akt2 Peptide, 2410016A19Rik Peptide, AW554154 Peptide, PKB Peptide, PKBbeta Peptide, HIHGHH Peptide, PKBB Peptide, PKBBETA Peptide, PRKBB Peptide, RAC-BETA Peptide, cb945 Peptide, akt2-a Peptide, AKT serine/threonine kinase 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 Peptide, thymoma viral proto-oncogene 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 L homeolog Peptide, AKT2 Peptide, akt2 Peptide, Akt2 Peptide, akt2.L Peptide
- Background
- RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, PKB beta, RAC-PK-beta
- Gene ID
- 208, 11652, 25233
- UniProt
- P31751, Q60823, P47197
-